in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes The 2-year interim analysis of the MIND.IT study: a cluster randomized trial

[1]  D. Ardigò,et al.  Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  K Khunti,et al.  Intensive multifactorial intervention improves modelled coronary heart disease risk in screen‐detected Type 2 diabetes mellitus: a cluster randomized controlled trial , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[3]  Kamlesh Khunti,et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.

[4]  G. Mancia,et al.  Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.

[5]  Eliseo Guallar,et al.  Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study , 2011, European heart journal.

[6]  C. J. Bailey,et al.  Patient adherence to medication requirements for therapy of type 2 diabetes , 2011, International journal of clinical practice.

[7]  Dirk De Bacquer,et al.  EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  A. Nicolucci,et al.  Four‐year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD‐Annals initiative , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[9]  R. Lyons,et al.  Population based absolute and relative survival to 1 year of people with diabetes following a myocardial infarction: A cohort study using hospital admissions data , 2010, BMC public health.

[10]  N. Sattar,et al.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.

[11]  W. Stewart,et al.  Factors Associated with First-Fill Adherence Rates for Diabetic Medications: A Cohort Study , 2009, Journal of general internal medicine.

[12]  M. Boemi,et al.  The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. , 2008, Atherosclerosis.

[13]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[14]  M. Engelgau,et al.  Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 19882002 , 2006, Annals of Internal Medicine.

[15]  Jay R. Desai,et al.  Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. , 2005, Diabetes care.

[16]  Jonathan L. Blitstein,et al.  Design and analysis of group-randomized trials: a review of recent methodological developments. , 2004, American journal of public health.

[17]  S. Kaplan,et al.  Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group--quality of care and outcomes in type 2 diabetes. , 2003, Archives of internal medicine.

[18]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[19]  Sid,et al.  [Guidelines for cardiovascular prevention in diabetic patients]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[20]  Allan Donner,et al.  Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .

[21]  R. Holman,et al.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.